Clendeninn Neil James 4

4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed May 28, 2013

Form 4

Period: 2013-05-23

Director

Transactions

Award
Stock Option (right to buy)
2013-05-24+5,000→ 5,000 total
Exercise: $10.73Exp: 2023-05-24→ Common Stock (5,000 underlying)
Exercise/Conversion
Restricted Stock Unit (RSU)
2013-05-23−2,000→ 0 total
From: 2013-05-23Exp: 2013-06-21→ Common Stock (2,000 underlying)
Award
Restricted Stock Unit (RSU)
2013-05-24+2,500→ 2,500 total
→ Common Stock (2,500 underlying)
Exercise/Conversion
Common Stock
2013-05-23$10.64/sh+2,000$21,280→ 9,562 total

Footnotes (5)

[F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
[F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
[F3]The options vest 100% on the earlier of May 24, 2014 or the date immediately prior to the issuer's next annual meeting of stockholders.
[F4]The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.
[F5]The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders.

Documents

1 file